Interplay between pioneer transcription factors and epigenetic modifiers in cell reprogramming
Regenerative Therapy · 2025-03 · 28 · 246-252
DOI: 10.1016/j.reth.2024.12.014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Regenerative Therapy, 2025-03. Verfasst von Gerardo Mirizio und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Developmental Biology, Center for Stem Cell & Organoid Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
The generation of induced pluripotent stem cells (iPSCs) from differentiated somatic cells by Yamanaka factors, including pioneer transcription factors (TFs), has greatly reshaped our traditional understanding of cell plasticity and demonstrated the remarkable potential of pioneer TFs. In addition to iPSC reprogramming, pioneer TFs are pivotal in direct reprogramming or transdifferentiation where somatic cells are converted into different cell types without passing through a pluripotent state. Pioneer TFs initiate a reprogramming process through chromatin opening, thereby establishing competence for new gene regulatory programs. The action of pioneer TFs is both influenced by and exerts influence on epigenetic regulation. Despite significant advances, many direct reprogramming processes remain inefficient, which limits their reliability for clinical applications. In this review, we discuss the molecular mechanisms underlying pioneer TF-driven reprogramming, with a focus on their interactions with epigenetic modifiers, including Polycomb repressive complexes (PRCs), nucleosome remodeling and deacetylase (NuRD) complexes, and the DNA methylation machinery. A deeper understanding of the dynamic interplay between pioneer TFs and epigenetic modifiers will be essential for advancing reprogramming technologies and unlocking their full clinical potential.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Developmental Biology, Center for Stem Cell & Organoid Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, USA.
- Department of Pediatrics, College of Medicine, University of Cincinnati, OH, 45229, USA.
Förderung
- NIDDK NIH HHS
- NIGMS NIH HHS
- National Institute of General Medical Sciences
- Cincinnati Children's Hospital Medical Center
- National Institutes of Health
- Cincinnati Children’s Research Foundation
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Mirizio, G., Sampson, S., & Iwafuchi, M. (2025). Interplay between pioneer transcription factors and epigenetic modifiers in cell reprogramming. Regenerative Therapy, 28, 246-252. https://doi.org/10.1016/j.reth.2024.12.014
Vancouver
Mirizio G, Sampson S, Iwafuchi M. Interplay between pioneer transcription factors and epigenetic modifiers in cell reprogramming. Regenerative Therapy. 2025;28:246-252. doi:10.1016/j.reth.2024.12.014
BibTeX
@article{Mirizio2025,
author = {Mirizio, Gerardo and Sampson, Samuel and Iwafuchi, Makiko},
title = {Interplay between pioneer transcription factors and epigenetic modifiers in cell reprogramming},
journal = {Regenerative Therapy},
year = {2025},
volume = {28},
pages = {246--252},
doi = {10.1016/j.reth.2024.12.014}
}
EUVIMED